KMID : 0939920190510010223
|
|
´ëÇѾÏÇÐȸÁö 2019 Volume.51 No. 1 p.223 ~ p.239
|
|
Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric Cancer
|
|
Kim Jin-Won
Kim Jong-Gwang Kang Byung-Woog Chung Ik-Joo Hong Young-Seon Kim Tae-You Song Hong-Suk Lee Kyung-Hee Zang Dae-Young Ko Yoon-Ho Song Eun-Kee Baek Jin-Ho Koo Dong-Hoe Oh So-Yeon Cho Ha-Na Lee Keun-Wook
|
|
Abstract
|
|
|
Purpose: The purpose of this study was to evaluate chemotherapy patterns and changes in quality of life (QOL) during first-line palliative chemotherapy for Korean patients with unresectable or metastatic/recurrent gastric cancer (GC).
Materials and Methods: Thiswas a non-interventional, multi-center, prospective, observational study of 527 patients in Korea. QOL assessments were conducted using the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaires (QLQ)-C30 and QLQ-STO22 every 3 months over a 12-month period during first-line palliative chemotherapy. The specific chemotherapy regimens were selected by individual clinicians.
Results: Most patients (93.2%) received combination chemotherapy (mainly fluoropyrimidine plus platinum) as their first-line palliative chemotherapy. The median progression-free survival and overall survival were 8.2 and 14.8 months, respectively. Overall, ¡°a little¡± changes (differences of 5-10 points from baseline)were observed in some of the functioning or symptom scales; none of the QOL scales showed either ¡°moderate¡± or ¡°very much¡± change (i.e., ¡Ã 11 point difference from baseline). When examining the best change in each QOL domain from baseline, scales related to some aspects of functioning, global health status/QOL, and most symptoms revealed significant improvements (p < 0.05). Throughout the course of first-line palliative chemotherapy, most patients¡¯ QOL was maintained to a similar degree, regardless of their actual response to chemotherapy.
Conclusion: This observational study provides important information on the chemotherapy patterns and QOL changes in Korean patientswith advanced GC. Overall, first-line palliative chemotherapy was found to maintain QOL, and most parameters showed an improvement compared with the baseline at some point during the course.
|
|
KEYWORD
|
|
Advanced gastric cancer, First-line palliative chemotherapy, Quality of life
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|